By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Aushon BioSystems today said that LightArray Biotech will provide the firm's multiplex biomarker products and services in China.

LightArray operates a drug development services lab in Wuxi, China. Aushon said that the firm will offer its biomarker technologies, including more than 300 validated assays, multiplex biomarker sample testing services and kits, custom arrays and assay development, and array imaging and analysis systems.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.